Norrsken VC is a Stockholm-based impact venture capital firm and part of the wider Norrsken ecosystem founded by Niklas Adalberth. It invests at early stage and growth in European companies tackling problems in energy, industry and healthcare, writing rounds of roughly EUR 1 million to EUR 10 million. The firm manages more than EUR 500 million and has over 60 portfolio companies.
Investment thesis
Backs founders solving the world's biggest challenges in energy, industry and healthcare, on the premise that the biggest returns come from solving the greatest problems.
Norrsken VC writes tickets between 1000000 and 10000000. Sesamers tracks 3 portfolio companies across 3 rounds, 2 of them as lead investor. Its most recent tracked deal: Orakl Oncology, Nov 2026.
Portfolio
Past investments
| Company | Round | Role | Date | Round size |
|---|---|---|---|---|
| Orakl Oncology Paris, France Read the announcement → | Series A | Lead | Nov 2026 | €30.8M |
| Sava London, United Kingdom Read the announcement → | Series B | Participant | Oct 2026 | €32.2M |
| Vocca Paris, France Read the announcement → | Series A | Lead | Oct 2026 | €17.8M |